By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Inference Research announces $20 Million Seed Round Led by Avenir Group to Build the AI-Native Quantitative Franchise
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > News > Inference Research announces $20 Million Seed Round Led by Avenir Group to Build the AI-Native Quantitative Franchise
Inference Research announces  Million Seed Round Led by Avenir Group to Build the AI-Native Quantitative Franchise
News

Inference Research announces $20 Million Seed Round Led by Avenir Group to Build the AI-Native Quantitative Franchise

Last updated: 12/02/2026 1:38 AM
Published: 12/02/2026
Share
SHARE

HONG KONG, Feb. 11, 2026 /PRNewswire/ — Inference Research, an AI-native quantitative trading franchise architected to capitalize on the convergence of Digital Assets and Traditional Finance, today announced its launch and the anticipated closing of a $20 million Seed funding round. The round was led by Avenir Group, a pioneering investment group that originated from Mr. Li Lin’s family office and is Asia’s prominent institutional investor.

- Advertisement -

Founded by Luke Li, the former Co-founder and Head of Trading at Amber Group, Inference Research is built to operate at the frontier of global market evolution—combining sovereign AI infrastructure with institutional trading discipline to tackle key challenges in modern markets, from asset pricing to liquidity provision, as global finance is being reshaped by AI and blockchain.

- Advertisement -

Strategic Partnership with Avenir Group The investment from Avenir Group validates Inference Research’s vision and provides the resources to accelerate infrastructure development and support scaling of its proprietary AI systems. As an industry pioneer dedicated to the integration of traditional finance and digital assets, Avenir Group’s strategic support enables Inference Research to pursue long-term growth with institutional-grade resilience and scale.

- Advertisement -

“Inference Research represents a compelling step forward in quantitative finance, blending institutional-grade discipline with AI-native innovation,” said Jacob Zhong, Managing Partner, Strategic Investment & Partnerships at Avenir Group. “This approach aligns closely with our mission to bridge traditional finance and digital assets, fostering resilient infrastructure and institutional adoption. We are proud to support Luke Li and the Inference Research team through strategic investment and incubation, contributing to a more unified and efficient global financial ecosystem.”

- Advertisement -

Building the Foundation The capital will be used to scale Inference Research’s sovereign infrastructure and accelerate the recruitment of world-class talent. The firm is assembling a team of exceptional quants, engineers, and researchers who value relentless curiosity and performance with integrity.

- Advertisement -

About Inference Research Inference Research is an AI-native quantitative trading franchise architected to capitalize on the convergence of Digital Assets and Traditional Finance. Combining sovereign AI technology with institutional trading discipline, the firm operates across digital assets, traditional markets, and emerging frontiers. For more information, visit www.infr.com.

- Advertisement -

About Avenir Group

- Advertisement -

Avenir Group is a pioneering investment group, originating from Mr. Li Lin’s family office, dedicated to the strategic integration of traditional finance and digital assets, driving innovation to build a leading financial ecosystem and infrastructure. Through an integrated framework of Investment, Incubation, and Operations, the group’s investments focus on digital assets, trading and financial service platforms, PayFi infrastructure, and Real-World Assets (RWA). As Asia’s largest institutional Bitcoin ETF holder, Avenir Group leads the regional market. With proven financial expertise and industry-leading capabilities, the group establishes its role as a global hub advancing capital mobility and strategic partnerships. Learn more: www.avenirx.com.

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/inference-research-announces-20-million-seed-round-led-by-avenir-group-to-build-the-ai-native-quantitative-franchise-302685354.html

- Advertisement -
Smile Spa Camarillo Officially Opens its Doors, Offering State-of-the-Art Dental Care in Ventura County
Mysore Saree Udyog Reimagines Its Digital Commerce Experience with Netcore Cloud, Achieving 8X ROI During the Festive Season
A New Era in Smart Living: ECOVACS Unveils DEEBOT X11 with PowerBoost Technology and Expands Service Robot Portfolio at IFA 2025
Zoomlion Advances Intelligent Manufacturing with Integrated AI and Embodied-Intelligence Robotics
Mphasis F1 Foundation and The/Nudge Prize’s Digital Naukri Challenge Announces Four Finalists to Scale Digital Livelihoods for Over 30,000 Women Across India
TAGGED:20%ai-native,announcesavenirbuildfranchisegroupinferenceledmillionnewsquantitativeResearchroundseedthe
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreatic Neuroendocrine Tumors at ESMO 2025
Health

ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreatic Neuroendocrine Tumors at ESMO 2025

GlobeNews Wire
GlobeNews Wire
18/10/2025
Clinisys acquires Orchard Software
LRS Output Management Announces Cloud-Based Print, Scan, and Auditing Suite
Secret Revealed to Earn Passive Income Easily in XRP, DOGE and Bitcoin with Cloud Mining Strategies
From 50,000 to 700,000 SKUs: Speed Parts Drives 20%+ Annual Growth with Maropost
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?